Ignite Creation Date:
2025-12-24 @ 11:43 PM
Ignite Modification Date:
2026-02-20 @ 5:08 AM
Study NCT ID:
NCT02368951
Status:
TERMINATED
Last Update Posted:
2017-07-12
First Post:
2015-02-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I, Dose-escalation Trial of BAY1187982 in Subjects With Advanced Solid Tumors Known to Express Fibroblast Growth Factor Receptor 2 (FGFR2)
Sponsor:
Bayer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-03-24
Start Date Type:
ACTUAL
Primary Completion Date:
2016-07-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-07-27
Completion Date Type:
ACTUAL
First Submit Date:
2015-02-16
First Submit QC Date:
None
Study First Post Date:
2015-02-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-07-10
Last Update Post Date:
2017-07-12
Last Update Post Date Type:
ACTUAL